Our Story, Our Purpose

Understand what it is that we do at Sigrid, why we do it, and for who we do it by watching our introductory video below.

Sigrid and SiPore21®

Our first product SiPore21® was developed by our two cofounders Sana Alajmovic and Tore Bengtsson to target prediabetics and newly diagnosed type 2 diabetics. SiPore21® is a silica-based medical device helping to lower blood sugar, body weight, and bad cholesterol and comes in a consumer-friendly easy-to-use sachet.

Learn more by watching the video!

Reach out to us